Diagnostic performance of (68)Gallium-PSMA-11 PET/CT to detect significant prostate cancer and comparison with (18)FEC PET/CT

BACKGROUND: Radiolabeled prostate-specific membrane antigen (PSMA) has proven to be a highly accurate method to detect recurrence and metastases of prostate cancer, but only sparse data is available about its performance in the diagnosis of clinically significant primary prostate cancer. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoffmann, Manuela A., Miederer, Matthias, Wieler, Helmut J., Ruf, Christian, Jakobs, Frank M., Schreckenberger, Mathias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762306/
https://www.ncbi.nlm.nih.gov/pubmed/29340038
http://dx.doi.org/10.18632/oncotarget.22441

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762306/
https://www.ncbi.nlm.nih.gov/pubmed/29340038
http://dx.doi.org/10.18632/oncotarget.22441

Ejemplares similares